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Abstract
We develop a new method for frequentist multiple testing with Bayesian prior information.
Our procedure finds a new set of optimal p-value weights called the Bayes weights. Prior
information is relevant to many multiple testing problems. Existing methods assume fixed,
known effect sizes available from previous studies. However, the case of uncertain information is
usually the norm. For a Gaussian prior on effect sizes, we show that finding the optimal weights
is a non-convex problem. Despite the non-convexity, we give an efficient algorithm that solves
this problem nearly exactly. We show that our method can discover new loci in genome-wide
association studies. On several data sets it compares favorably to other methods. Open source
code is available.
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1 Introduction
We are motivated by the genetics of human longevity. Genome-wide association studies of longevity
compare long-lived individuals (e.g. centenarians who live to 100 or older) to matched controls
(Brooks-Wilson, 2013). More than 500,000 genetic variants are tested for association to longevity.
This is a large multiple testing problem. In addition to the multiplicity, the sample size is low -
usually a few hundred. As a consequence, only a few loci have been replicably associated to human
longevity. They do not explain the heritability of the trait (Hjelmborg et al., 2006).
The multiplicity may be countered by testing only a few candidate variants selected based on
prior scientific knowledge. In a separate work in preparation, led by Dr. Kristen Fortney, we
find that a more general genome-wide test helps improve power in longevity. We leverage prior
information from genome-wide association studies of age-related diseases, such as coronary artery
disease and diabetes. For this task, we develop a new method of frequentist multiple testing with
Bayesian prior information. In this paper we provide the theory for this method.
Our method is a type of p-value weighting scheme. P-value weighting is a general methodology
for multiple testing that leverages independent prior information to improve power (see Roeder and
Wasserman (2009); Gui et al. (2012) for a review). Suppose we test hypotheses Hi i = 1, 2, . . . J ,
via the p-values Pi. For a significance level q ∈ [0, 1], the weighted Bonferroni method declares the
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i-th hypothesis significant if Pi ≤ qwi. The weights wi ≥ 0 are based on independent data. For
weights averaging to 1, the family-wise error rate (the probability of making at least one error) is
controlled strongly at α = Jq.
Previous work has found the optimal weights in a Gaussian model of hypothesis testing. Let
the test statistics in the current study be Ti ∼ N (µi, 1), where µi are the means, or effect sizes,
and test the null hypotheses µi ≥ 0 against µi < 0. We have some information about µi from
prior studies. The works Wasserman and Roeder (2006); Roeder and Wasserman (2009); Rubin
et al. (2006) consider the model where µi is known exactly from the prior data, and the weights
are allowed to depend on µi. In this model they find the optimal weights maximizing the expected
number of discoveries. We show this amounts to solving a convex optimization problem, but this
was not used originally.
The assumption that µi are known precisely is problematic: if they were known, there should be
no follow-up study. Instead, we account for uncertainty by considering the model µi ∼ N (ηi, σ2i ).
Here only the prior mean ηi and standard error σi are known from independent data, not the
precise value of the effect sizes. However, finding the optimal weights, which we call Bayes weights,
becomes a non-convex optimization problem. Westfall et al. (1998) use a direct numerical solver,
and optimize for at most 4 tests.
We give an efficient method to find the optimal weights for a large number of tests. We solve
the optimization problem exactly for small q. For larger q, we can solve it for a nearby q∗ such that
|q∗−q| ≤ 1/(2J). The cost in the first case is O(J), the cost in the second case is O(J log J). These
are the costs per iteration of our optimization algorithm. We observe a near constant number of
iterations used. The solution of non-convex optimization problems is challenging in general, thus
it is perhaps remarkable that this problem admits a nearly exact solution.
This enables a new methodology for large-scale multiple testing that controls a frequentist error
measure, while also taking into account Bayesian prior information. This method follows George
Box’s advice to be Bayesian when predicting but frequentist when testing (Box, 1980). While this
methodology was considered previously for a few tests (Westfall et al., 1998), we are the first to do
it on a large scale.
When prior information is uncertain, we show in simulations that the new scheme does better
than its competitors. We also show theoretically, in a sparse mixture model, that weighting leads to
substantially improved power. We apply our method to genome-wide association studies (GWAS).
By analyzing several GWAS data sets we show its advantages compared to other methods.
This method should be useful for other problems in biology and elsewhere. Open source code is
available from the authors. All our computational results are reproducible (see the Supplement).
The contents of the paper are as follows: We discuss related work in Section 2. We develop
the theory in Section 3 and present simulations comparing our method to alternatives in Section
4. We apply our method to genome-wide association studies in Section 5 and use it to analyze
GWAS data in Section 6. The supplementary material contains a description of available software
and instructions to reproduce our computational results (Section 8), as well as mathematical proofs
(Section 9).
2 Related Work
There is a large literature on related statistical methods for multiple testing with prior information.
In early work, Spjotvoll (1972) devised optimal multiple testing procedures treating tests unequally.
Later it was recognized that Spjotvoll’s results are equivalent to optimal p-value weighting methods.
For instance, Benjamini and Hochberg (1997) developed extensions of Spjotvoll’s methods for p-
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value weighting.
Leveraging Spjotvoll’s results, Wasserman and Roeder (2006); Roeder and Wasserman (2009);
Rubin et al. (2006) found the explicit formula for optimal weights in the Gaussian model N (µi, 1),
assuming the effects are known exactly. This lead to an efficient method suitable for large appli-
cations. In the bioinformatics community Eskin (2008); Darnell et al. (2012) applied Wasserman
and Roeder (2006)’s framework to GWAS. They accounted for correlations between the tests but
assumed the effects are known exactly.
The simple method of testing the top candidates from a prior study is also popular. This is
often known as two-stage testing or as a candidate study. A specific version for GWAS has been
called the proxy-phenotype method (Rietveld et al., 2014). Using only the top candidates runs the
risk of discarding many potentially useful hypotheses.
A missing ingredient is taking uncertainty into account. Westfall et al. (1998) considered a
Gaussian model N (µi, 1) for hypothesis testing where prior distributions are known for the means.
However, their optimization methods could handle only a small number (J = 4) of tests.
3 Theoretical results
3.1 Background
In this section we present our theoretical results. As background, we begin with the case of known
means. We work in the Gaussian means model of hypothesis testing: We observe test statistics
Ti ∼ N (µi, 1) and test each null hypothesis Hi : µi ≥ 0 against µi < 0. The p-value for testing Hi
is Pi = Φ(Ti), where Φ is the normal cumulative distribution function.
For a weight vector w ∈ [0,∞)J and significance level q ∈ [0, 1], the weighted Bonferroni
procedure rejects Hi if Pi ≤ qwi. Usual Bonferroni corresponds to wi = 1. Then the expected
number of false rejections, known as the per-family error rate, equals:
∑
µi≥0 pr(Pi ≤ qwi) =
q
∑
µi≥0wi. Therefore, if
∑J
i=1wi ≤ J , the expected number of false rejections is controlled strongly,
under any configuration of truth or falsehood of Hi, at α := Jq. By Markov’s inequality this implies
that the family-wise error rate, the probability of any false rejection, is also controlled at α. This
does not need independence of the Ti. We always assume that q ≤ 1, and usually q  1. Without
loss of generality we restrict the weights to [0, 1/q].
Let us denote the number of rejections by R(w) =
∑J
i=1 I(Pi ≤ qwi), where I(·) is the indicator
function. The optimal weights in this model were found explicitly by Wasserman and Roeder
(2006); Roeder and Wasserman (2009) and independently by Rubin et al. (2006). Denoting by
ET (·) expectation with respect to Ti, they solve the constrained optimization problem
max
w∈[0,1/q]J
ET {R(w)} subject to
J∑
i=1
wi = J. (1)
It was not noted in these works that this problem is convex. Usually convex programs are about
minimization of convex functions. This is equivalent to maximizing concave functions. In our case
the objective is a sum of terms of the form Φ{Φ−1(qwi)− µi}, whose concavity follows directly by
differentiation. Yet, by simple Langrangian optimization, the above papers show that if all µi < 0,
the optimal weights are wi = w(µi), where
w(µ) = Φ
(
µ
2
+
c
µ
)
/q. (2)
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Here c is the unique normalizing constant such that the weights sum to J . Interestingly, the
weights are not monotonic as a function of µ, but maximal for intermediate values of µ (Roeder
and Wasserman, 2009).
As noted by Roeder and Wasserman (2009) the formula is a direct consequence of Spjotvoll’s
theory of optimality in multiple testing (Spjotvoll, 1972). Accordingly, we call these the Spjotvoll
weights.
3.2 Weighting leads to a substantial power gain
To illustrate theoretically that weighting can lead to increased power, we compare the power of
optimal weighting and unweighted testing in a sparse mixture model.
P-value weighting exploits the heterogeneity of the tests. In the simplest case there are only
large and small effects, say M  m ≈ 0. We want the m→ 0 limit, and for simplicity we suppose
m = 0. Similar results hold if m ≈ 0. Let the fraction of large and small means be pi1, pi0 > 0, so
that pi1J means are M , and the remaining pi0J are 0. We solve below for the optimal weights.
Proposition 3.1 (Optimal weights for sparse means). There is a set of optimal weights that gives
the same weight to equal means, w0 and w1 to 0 and M . These are:
(w0, w1) =
{
(0, 1/pi1) if pi1Φ(−|M |/2) > q,{
q−pi1Φ(−|M |/2)
qpi0
, Φ(−|M |/2)q
}
if pi1Φ(−|M |/2) ≤ q.
Further, the power p∗ of the optimal p-value weighting method is:
p∗(pi1,M, q) =
{
pi1Φ
{
Φ−1(q/pi1) + |M |
}
if pi1Φ(−|M |/2) > q,
q + pi1 {Φ(|M |/2)− Φ(−|M |/2)} if pi1Φ(−|M |/2) ≤ q.
If |M | is small enough that pi1Φ(−|M |/2) > q, all the weight is placed on the larger means.
This is the behavior we expect intuitively. However, if |M | is large enough that pi1Φ(−|M |/2) ≤ q,
then it is advantageous to place some weight on the small means. The reason is that such a large
|M | will be detected with very high probability.
The power of unweighted Bonferroni is punif(pi1,M, q) = pi0q + pi1Φ{Φ−1(q) + |M |}.
In Figure 1 (a), we plot the ratio of p∗(pi1,M, q)/punif(pi1,M, q) for q = 10−3 for a range of M
and pi1. We observe that for most effect sizes M ∈ [−2.5,−0.25], and pi1 < 0.4, we get a power
boost of at least 50%. Further, there is a hotspot where the power gain can be 3-4 fold. Thus,
optimal weighting can lead to a significant boost in power.
3.3 Weights with imperfect prior knowledge
In the previous sections it was assumed that the effects µi were known precisely. We will instead
assume that we have uncertain prior information µi ∼ N (ηi, σ2i ) about them.
We maximize the expected power Eµ[ET {R(w)}]. The expectation is with respect to the random
Ti and µi. Introducing γi = (σ
2
i + 1)
1/2, the Bayes weights problem becomes:
max
w∈[0,1/q]J
J∑
i=1
Φ
{
Φ−1(qwi)− ηi
γi
}
subject to
J∑
i=1
wi = J. (3)
This objective is not concave if any γi > 1. To help with visualization, the function w →
Φ[{Φ−1(qw) − η}/γ] is plotted in Figure 1 (b) for four parameter pairs (η, γ). The function is
increasing, and its curvature has two intervals: concavity, followed by convexity.
5
1.
5
1.5
1.5
2
2
2.5
2.5
33.54
M
-5 -4 -3 -2 -1 0
: 1
0
0.1
0.2
0.3
0.4
(a) Power gain.
w
0 5 10 15 20
0
0.2
0.4
0.6
0.8
1
(b) Non-convex summand.
Figure 1: (a) Contour plot of power ratio of optimal and unweighted testing for sparse means. (b)
Plots of four different instances of the function that is summed in the optimization objective. The
non-convex function w → Φ[{Φ−1(qw)−η}/γ] with q = 0.05 is plotted for the following pairs (η, σ):
(−0 · 1, 1) solid, (−0 · 1, 2) dashed, (−1, 1) dotted, (−1, 2) dot-dashed.
Our key contribution is to solve this problem efficiently for large J . Our results here are twofold.
First, we can solve the problem exactly in the special case when q is sufficiently small. Second, we
have a nearly exact solution for arbitrary q. We start with the simpler first case. Let us define
c(η, γ;λ) = −η + γ{η
2 + 2
(
γ2 − 1) log(γλ)}1/2
γ2 − 1 . (4)
It turns out that c is the optimal critical value when
q ≤ 1
J
J∑
i=1
Φ {c(ηi, γi; 1)} . (5)
In our data analysis examples and simulations, this upper bound requires that q be below values
in the range 0 · 1− 0 · 3. In the next result we find the exact optimal weights for small q when all
σi > 0.
Theorem 3.2 (Form of Bayes weights). If the significance level q ∈ [0, 1] is small enough that (5)
holds then the optimal Bayes weights maximizing the average power (3) are wi = w(ηi, γi;λ) =
Φ{c(ηi, γi;λ)}/q, where λ ≥ 1 is the unique constant such that
∑J
i=1w(ηi, γi;λ) = J .
In the supplementary material, we solve this problem by maximizing the Lagrangian. The two
key properties are the joint separability of the objective and constraint; and the analytic tractability
of the Gaussian.
Figure 2 shows surface and contour plots of an instance of the optimal weights w(η, σ), as a
function of the mean η and standard deviation σ. In the theorem the weights are a function of (η, γ).
Here and below, we will often view them as a function of (η, σ), via the natural map γ2 = σ2 + 1.
As the standard error σ becomes small, our weights tend to the Spjotvoll weights:
Proposition 3.3 (Recovering the Spjotvoll weights). For any λ and η < 0, the Bayes weight
function defined by w(η, γ;λ) = Φ{c(η, γ;λ)}/q tends to the Spjotvoll weight defined in (2) as
σ → 0.
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Figure 2: Bayes weights: (a) surface and (b) contour plots of the Bayes weight function w(η, σ)
defined in Theorem 3.2. Spjotvoll weights are on the segment σ = 0, η < 0.
With σi > 0, the weights are regularized: more extreme weights are shrunk towards a common
value in a nonlinear way. For finite σi our weights can be viewed as a smooth interpolation between
Spjotvoll and uniform weights. It is reasonable to think at first that as all σi → ∞, the best
weight allocation is uniform. This is not the case. As we will show below, an interesting symmetry
breaking phenomenon occurs.
Consider a weight vector w that equals 1/q for bJqc indices, and assume Jq is not an integer.
Distribute the remaining strictly positive weight equally among the remaining hypotheses. Now it
is easy to see that for the 1/q weights we always reject, thus the power equals 1. For the remaining
weights the objective Φ[{Φ−1(qw) − η}/γ] tends to Φ(0) = 1/2 as σ → ∞ (i.e. γ → ∞). This
shows that the limiting power is bJqc+ (J − bJqc)/2 = (J + bJqc)/2. This is larger than J/2, the
limit power of uniform weighting! This illustrates the symmetry breaking phenomenon caused by
the extreme non-convexity of the optimization problem.
Fortunately the situation is better as long as condition (5) holds. This condition is easy to check
for any given parameters q and (ηi, σi), i = 1, . . . , J . In addition we will now show theoretically
that the constraint is mild. Often, even if J is large, we want to keep α = Jq small, because α is
the number of false rejections we tolerate. In this regime the condition holds as long as there are
a few average-sized negative prior means ηi (denote zc = Φ
−1(c)).
Proposition 3.4 (Simple condition). Condition (5) is true (and so Theorem 3.2 applies) if there
are K distinct indices i with negative ηi, such that γ
2
i log(γ
2
i )/|zα/K | ≤ |ηi| ≤ |zα/K |.
If α/K → 0, it is well-known that asymptotically |zα/K | ∼ {2 log(K/α)}1/2, so the simple
condition holds as long as: γ2i log(γ
2
i ){2 log(K/α)}−1/2 . |ηi| . {2 log(K/α)}1/2. This is a quite
weak requirement. For instance, if K = 10, α = 0 · 01, then {2 log(K/α)}1/2 approximately equals
3.7. Continuing this example, if σ = 1, so that γ2 = 2, and γ2 log(γ2)/3.7 = 0.16, then we only
need 10 hypotheses with 0.16 ≤ |η| ≤ 3.7.
When q is small, we use Newton’s method to find the right constant λ from the theorem via a
one-dimensional line search. The function evaluations cost O(J) per iteration, and empirically it
takes a small number of iterations independent of J to converge. In our data analysis section, we
solve problems with more than 2 million tests in a few seconds on a desktop computer.
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Figure 3: Power of four p-value weighting methods as a function of their parameter. Unweighted
(solid), Bayes (dashed) as a function of the dispersion φ, exponential (dotted) as a function of β,
and filtering (dot-dashed) as a function of |M |. The Spjotvoll weights correspond to the point at
the origin φ = 0 on the Bayes weights curve.
Now we move to presenting our result for the general case.
Theorem 3.5 (Weights in the general case). For any q ∈ [0, 1], the non-convex Bayes weights
problem can be solved for a nearby q∗ ∈ [0, 1], for which |q∗ − q| ≤ 1/(2J). The optimal weights
and q∗ can be found in O(J log J) steps.
This result is most relevant for the settings when α = Jq, the expected number of errors under
the null, is set to at least 1/2. If so, and especially for large J , our weights will be optimal for a
q∗ that is close to q. We see from the proof that even for large q, q∗ often equals q. The method
also returns the value q∗, which the user can inspect. It is then up to the user to choose whether
to perform multiple testing adjustment at the original level q or at the new level q∗.
We note that the analysis of non-convex optimization problems is challenging in general. It is
perhaps remarkable that the non-convex Bayes weights problem admits a nearly exact solution.
4 Simulation studies
4.1 Bayes weights are more powerful than competing methods
We present two simulation studies to explore the empirical performance of our method. First we
show that Bayes weights increase power more reliably than competing methods. We compare three
methods of p-value weighting: Bayes, exponential, and filtering.
For Bayes weights we multiply the variances by a dispersion factor φ: N (ηi, φσ2i ). By changing
the dispersion, we test the robustness of our method to mis-specification of the prior variances.
This corresponds to the same dispersion variable φ in our GWAS application given in the next
section. The dispersion ranges from 0 to 4. Spjotvoll weights correspond to φ = 0.
Exponential weights with tilt β are defined as: wi = exp(β|ηi|)/c, where c =
∑J
i=1 exp(β|ηi|).
This weighting scheme was proposed in (Roeder et al., 2006), who recommend β = 2 as a default.
We include the range β ∈ [0, 4]. As noted by Roeder et al. (2006), exponential weights are sensitive
to large means. To guard against this sensitivity, we truncate the weights larger than 1/q and
re-distribute their excess weight among the next largest weights.
Filtering methods test only the most significant effects ηi ≤ M , and give them equal weights.
This and related methods are known under many names, such as two-stage testing, screening, or
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the proxy phenotype method (Rietveld et al., 2014). We adopt the name filtering from Bourgon
et al. (2010), who filter based on independent information in the current data set instead of prior
information. The threshold M ranges from −4 to 0. If |M | is large and fewer than Jq hypotheses
would be tested, then we instead test the most significant Jq.
The simulation is conducted as follows: We generate J = 1000 random means and variances
independently according to ηi ∼ N (0, 1), σi ∼ |N (0, 1)|. We set q = 10−2. For any weight vector
w, we calculate the power as the objective from (3) divided by J , to reflect the average power per
test.
The results are shown in Figure 3. Each method can improve the power over unweighted testing.
However, Bayes weights lead to more power than the other methods. The best power is attained
when the dispersion φ = 1, but good power is reached even when φ is not 1. Our weights are robust
to mis-specifying the dispersion.
Note, in particular, that taking uncertainty into account helps. Spjotvoll weights, which assume
fixed and known effects, and are shown on the figure as regularized weights with φ = 0, have less
power than Bayes weights with positive φ, for a wide range of φ.
The remaining two methods, filtering and exponential weights, have disadvantages. While
filtering leads to power gain for a thresholding parameter M . 3/4, it also leads to a substantial
power loss for M > 1. For sufficiently large M the power equals q, because only the top Jq
hypotheses are selected. Further, it is a significant disadvantage that there is no principled way to
choose M a priori without additional assumptions.
Similarly, exponential weighting leads to at most a small gain in power, and usually leads to a
loss. There also appears to be no simple, principled way to choose β a priori.
We conclude that Bayes weights are quite insensitive to tuning and have uniformly good power.
In contrast, exponential weighting and filtering are relatively sensitive and their power can drop
substantially. Therefore, Bayes weights increase power more reliably than competing methods.
4.2 Bayes weights have a worst-case advantage
We show that Bayes weights have a worst-case advantage compared to Spjotvoll weights. We
use the sparse means model: we generate J = 1000 means ηi, such that their distribution is
η ∼ pi0δm + pi1δM , where m = −10−3 and M = −2. We set q = 10−2 and we vary pi1 from 0 to 0.1.
We set all σi = σ.
We consider two values of σ: 0 and 1. Spjotvoll is optimal for σ = 0, while Bayes weights with
σ = 1 are optimal for 1. We evaluate these weighting schemes by calculating the objective that they
do not maximize: the average power (3) for Spjotvoll and the deterministic power (1) for Bayes
weighting. We also compute the power of the unweighted Bonferroni method.
The results are in Figure 4. Bayes weights lose only a little compared to the optimal Spjotvoll
((a) left). In contrast, Spjotvoll loses a lot compared to Bayes ((a) right). Bayes maximizes the
worst-case power, thus showing a maximin property.
Spjotvoll weights show a marked drop in power near pi1 = 0.07, as shown by its non-monotonic
power curve in Figure 4 (a)). To understand this, we plot the two weighting schemes in Figure 4
(b). Since there are only two classes, the weights also take two values. We see that the Spjotvoll
weights are more extreme than the Bayes ones. They start putting weight equal to zero on the
small means near pi1 = 0.07, which appears to lead to power loss.
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Figure 4: (a) Deterministic (left) and average (right) power as a function of the proportion of large
means pi1. Three methods are compared: unweighted (solid), Spjotvoll (dashed), Bayes (dotted).
(b) The weights of the two classes, large (solid) and small (dashed), for Spjotvoll (left) and Bayes
(right), as a function of the proportion of large means pi1.
5 Application to Genome-Wide Association Studies
5.1 Review of GWAS
We adapt our framework to genome-wide association studies, relying on basic notions of quantitative
genetics (see e.g. Lynch and Walsh, 1998). Our method applied to this problem is called iGWAS in
our forthcoming application to human longevity. This section presents in detail the methodology
for that application, while also illustrating the steps to use our framework for specific problems.
Consider a model for GWAS in which we study a quantitative trait y in a population. Our goal
is to understand the effects of single nucleotide polymorphisms (SNPs) g1, g2, . . . , gJ on the trait.
We assume y has mean 0 and known variance, and gi denotes the centered minor allele count of
variant i for an individual. We rely on the linear model for the effect of the i-th variant on the
trait: y = giβi + εi.
We will show how our question can be framed in the Gaussian means model of hypothesis testing.
In the above model y is the phenotype of a randomly sampled individual from the population.
Accordingly, gi is random, βi is a fixed unknown constant, and εi is the residual error. This error
is a mean-zero random variable independent of gi, with variance σ
2
i .
Suppose we observe a sample of N independent and identically distributed observations from
this model. We use the standard linear regression estimate βˆi, which for large sample size has an
approximate distribution N1/2βˆi
.∼ N{N1/2βi, σ2i /var(gi)}. We can standardize if we divide by τi,
where τ2i = σ
2
i /var(gi) is the variance of N
1/2βˆi.
With these steps, we have framed our problem in the Gaussian means model. Denoting Ti =
N1/2βˆi/τi, µi = N
1/2βi/τi, we have Ti
.∼ N (µi, 1), which is the required form. Denote also the
standardized effect size νi = βi/τi, which will be of key importance.
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5.2 Prior Information
Now we show how to use prior information. Assume we also have a prior trait y0 measured
independently on a different, independent sample from the same population. If our assumptions
also hold for y0, we can write y0 = giβ0i + ε0i. Here β0i is a fixed unknown constant, and ε0i is
random. Suppose we have independent samples of size Ni and N0i for the two traits. If we define
T0i, ν0i by analogy to their definitions for y, we can write T0i ∼ N (N1/20i ν0i, 1).
We model the relatedness between the two traits as a relation between the standardized effect
sizes ν, which do not depend on the sample size. If the two traits are closely related, the first order
approximation is equality: νi = ν0i. This simple model captures the pleiotropy between the two
traits (e.g. Solovieff et al., 2013).
The final step is to compute the distribution of νi given the prior data T0i. For this we need to
choose a prior for νi, and for simplicity we will use a flat prior.
We now have all ingredients to apply the model for Gaussian hypothesis testing with uncertain
information. Specifically, we have µi ∼ N (ηi, σ2i ), where µi = N1/2i νi, ηi = (Ni/N0i)1/2T0i, and
σ2i = Ni/N0i.
The uncertainty in T0i may be different from 1, for instance larger than 1 due to overdispersion.
In addition, overdispersion is one way to weaken the first order approximation assumption. To
allow for this, we recall the dispersion parameter φ used in our simulation. We model the prior
data as T0i ∼ N (N1/20i ν0i, φ). Then the variance σ2i = φNi/N0i. The default is φ = 1. Finally, we
compute Bayes weights wi with parameters q, (ηi, σ
2
i ), and run weighted Bonferroni on the current
p-values. This fully specifies the method. For the reader’s convenience, the method is summarized
in Algorithm (1).
Algorithm 1 Multiple Testing with Bayes weights in GWAS
T0i ← prior effect sizes for i = 1, . . . , J
N0i, Ni ← prior and current sample sizes
Pi ← current p-values
q ← significance threshold
φ← dispersion (default φ = 1)
Set the prior means and variances: ηi = (Ni/N0i)
1/2T0i, σ
2
i = φNi/N0i
Compute Bayes weights wi, defined via (3), with parameters q, (ηi, σ
2
i )
Return indices i such that Pi ≤ qwi
5.3 Practical remarks
It is important that we retain type I error control as soon as we have valid p-values, even if the
modelling assumptions fail. Common deviations from our model are: (1) GWAS summary data
sometimes only has the magnitude of the effects, and not their sign. In this case we have two
choices. We may assume that the directions of effects are the same, and do a one-tailed test of the
current effect in the prior direction. Alternatively, we can do a two-tailed test by including the 2
tests (ηi, σ
2
i ) and (−ηi, σ2i ) for each i, for a total of 2J tests. (2) When the prior and current trait
are not both quantitative, and one is binary, the model νi = ν0i should be re-examined. It is still
convenient as a first approximation. (3) Benjamini-Hochberg may be used instead of Bonferroni,
with any weights summing to J , for increased power (Genovese et al., 2006).
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6 Data Analysis
6.1 Data Sources
We illustrate our method by analyzing 5 publicly available genome-wide association studies of
quantitative or binary traits. We use the association p-values, which are available for 500,000
to 2.5 million SNPs. The five studies are: CARDIoGRAM and C4D for coronary artery disease
(Schunkert et al., 2011; Coronary Artery Disease (C4D) Genetics Consortium, 2011), and one each
for the kidney trait estimated glomerular filtration rate (eGFR) creatinine (Ko¨ttgen et al., 2010),
blood lipids (Teslovich et al., 2010), and schizophrenia (Schizophrenia Psychiatric Genome-Wide
Association Study (GWAS) Consortium, 2011). CARDIoGRAM and C4D include non-overlapping
samples. A detailed description appears in the Supplementary material.
6.2 Specific Pairs
We analyze three pairs of data sets, with specific motivation for each. First, we use CARDIoGRAM
as prior information for C4D. This is a ‘positive control’ for our method, since both studies measure
the same phenotype, coronary artery disease. Therefore the weights should increase power. We
choose C4D as target because it has smaller sample size; hence prior information may increase
power more substantially.
Second, we use the blood lipids GWAS as prior information for schizophrenia. Andreassen
et al. (2013) showed improved power with this pair. They developed and controlled the Bayesian
conditional false discovery rate. This is not known to control a frequentist criterion. Our goal was
to evaluate the power improvement using a frequentist method. As Andreassen et al. (2013) noted,
there is a small overlap between the controls of the two GWAS (Section 10).
Third, we used the eGFR creatinine GWAS as prior information for the C4D coronary artery
disease study. Heart disease and renal disease are comorbid (eg. Silverberg et al., 2004), so it is
possible that this may improve power. Here the hypothesized improvement is not based on entirely
rigorous arguments.
6.3 Methods compared
We run weighted Bonferroni multiple testing for each of the 5 weighting schemes. The prior data
is T0i = Φ
−1(P0i/2), where P0i is the i-th prior p-value. The family-wise error rate is controlled at
q = 0.05.
The first four methods are: unweighted Bonferroni, where all weights equal 1; Spjotvoll weights
with parameters µi = (Ni/N0i)
1/2T0i; Bayes weights defined in Section 5, with dispersion φ = 0.1, 1,
and 10; and exponential weighting (Roeder et al., 2006) with tilt β = 1, 2, and 4, introduced in
Section 4.1.
The fifth and last method is filtering, which selects the smallest p-values in the prior study,
and tests their SNPs in the current study. We use three p-value thresholds P < 10−2, 10−4, 10−6.
Rietveld et al. (2014) propose a method to choose the optimal p-value threshold for filtering.
This needs the genotypic correlation between the two traits and the additive heritability of the
current trait. For complex traits these parameters are usually estimated with a large uncertainty.
Substantial domain expertise is required to choose the right parameter.
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6.4 Additional details
We prune the significant SNPs for linkage disequilibrium (LD) using the DistiLD database (Palleja
et al., 2012). We LD prune the significant SNPs for each method by selecting one SNP from each
LD block. Our data analysis pipeline is available from the first author.
We compute a score sm(p)d for each method m with parameters p, on each data set d. This is
defined as +1 if the method increases the number of hits compared to unweighted, 0 if it leaves
it unchanged, and -1 otherwise. The score sm(p) of a method m with parameters p is the sum of
scores across data sets. The total sm of the method m is the sum of scores sm(p) across parameters.
6.5 Results
Table 1: Number of significant SNPs of five methods on three examples. Top: Results pruned
for linkage disequilibrium (LD). Middle: results without LD pruning. Bottom: The score of each
method. The methods compared are unweighted (Un); Spjotvoll (Spjot); Bayes with φ = 0 ·1, 1, 10;
exponential (Exp) with β = 1, 2, 4 and filtering (Filter) with − log(P ) = 2, 4, 6. CG stands for
CARDIoGRAM
Un Spjot Bayes(φ) Exp(β) Filter(− logP )
Parameter 0 · 1 1 10 1 2 4 2 4 6
LD Pruned
CG → C4D 4 11 10 8 4 4 5 4 10 10 6
Lipids → SCZ 4 1 1 1 5 1 0 0 2 2 2
eGFRcrea → C4D 4 2 2 4 4 4 5 4 1 0 1
Unpruned
CG→ C4D 29 45 44 39 29 32 34 27 40 48 34
Lipids → SCZ 116 214 214 223 123 92 0 0 217 96 39
eGFRcrea → C4D 29 18 18 23 29 29 28 19 1 0 1
Scoring
Score 0 0 0 1 1 0 0 −1 0 −1 −1
Total 0 0 sum = 2 sum = −1 sum = −2
The results of our data analysis are presented in Table 1. This table has the number of significant
SNPs on the pairs of GWAS data in 6.2 using the weights in 6.3. We also present the LD pruned
results, which are a proxy for the the number of independent loci found.
The results are somewhat inconclusive. On the positive control example, all methods except
exponential weighting improve power. Spjotvoll weighting and filtering have the largest number of
SNPs. On the blood lipids example, methods generally lose power for LD pruned SNPs (except
Bayes weights with φ = 10); and methods can both lose and gain power for non-LD pruned
SNPs (except Bayes weights which uniformly improves power). On the other hand, for the eGFR
creatinine example, exponential weights show the best behavior. We also see that the default φ = 1
is never worse that both unweighted and Spjotvoll, and for the unpruned lipids example it is better.
If we allow for tuning of parameters, Bayes weights show a good performance. They are either
first or second in all examples, and other methods rank lower. However, since we don’t have a
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principled way to tune the parameters, we do not pursue this way of evaluation.
Instead, we look at the scoring method for evaluation. The only method with a positive score is
our Bayes weights (φ = 1 and 10). The total score, summed across parameter settings, is also only
positive for Bayes testing. This shows some promise for our method. However, from this analysis
alone we cannot establish conclusively the relative merits of the methods. In future work it will be
necessary to evaluate p-value weighting methods on more data sets.
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Supplementary material
The supplementary material is organized as follows: Accessing the software implementation of our
method is described in Section 8. In Section 9 we give the proofs of all mathematical claims from
the paper. In addition, in Subsection 9.5.2 we give Algorithm 2 to compute our weights. In Section
10 describe our data sources in detail.
8 Software
8.1 End-user software
We provide R and MATLAB implementations of the methods developed in this paper. They can
be obtained from public git repositories or directly from the first author. The Matlab implemen-
tation is available from https://github.com/edgardobriban/pvalue_weighting_matlab. The
R implementation is available from https://github.com/edgardobriban/pvalue_weighting_r.
An R package is under development.
8.2 Reproducibility
All computational results and analyses of this paper have been performed in a reproducible way.
To reproduce the simulation results and figures, we provide the source code in the above-mentioned
Matlab package at https://github.com/edgardobriban/pvalue_weighting_matlab. To repro-
duce the data analyses, a separate repository has been created, and is publically available at
https://bitbucket.org/edgardobriban/pvalue-weighting-gwas.
9 Proofs
9.1 Proof of Proposition 1 - Sparse Means
Proof. The objective function we need to maximize in wi is
J∑
i=1
Φ{Φ−1(qwi)− µi}.
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We know that out of the J means µi, pi0J are equal to 0. For each of these, the summand in
the objective simplifies to qwi. For the remaining pi1J means, the same convex objective g(w) =
Φ{Φ−1(qwi)− µi} is summed, and the objective becomes:
q
∑
i:µi=0
wi +
∑
i:µi=M
g(wi).
Now, since g is convex, we have
∑
i:µi=M
g(wi) ≤ Mg(w¯), where w¯ is the mean of the weights
of large effects w¯ = (Jpi1)
−1(
∑
i:µi=M
wi). Hence, there is a set of optimal weights that take equal
values for equal means. This proves the first claim in the proposition.
If we call w0, w1 the weights for 0 and M , the optimization problem takes the form
max
w0,w1∈[0,1/q]
pi0w0 + pi1Φ
(
Φ−1(qwi)−M
)
s.t. pi0w0 + pi1w1 = 1.
Next, recall that qwi ≤ 1 and introduce a new set of variables ci := Φ−1(qwi). If qwi = 1, then
ci will take the value +∞ in the extended real number system R = R ∪ {∞}. All our calculations
respect the rules of the extended number system, so this will not cause any problems. For instance,
Φ(∞) is defined as 1 by continuity.
Then the optimization problem becomes
max
c0,c1∈R
pi0Φ (c0) + pi1Φ (c1 −M) s.t. pi0Φ (c0) + pi1Φ (c1) = q.
Substituting the second equation we find that we need to maximize
q + pi1 (Φ (c1 −M)− Φ (c1))
subject to pi1Φ (c1) ≤ q. Now it is easy calculus to check that the function c→ Φ (c−M)−Φ (c) is
strictly increasing on (−∞,M/2] and strictly decreasing on [M/2,∞). Therefore, if M/2 is feasible,
i.e. pi1Φ (M/2) ≤ q, then the maximum is achieved at c1 = M/2. This leads to the claimed formula
for w1 = Φ(c1)/q and the power p
∗.
If M/2 is not feasible, then the maximum is achieved at the largest feasible value c1, defined by
pi1Φ (c1) = q. This again leads to the claimed formulas.
9.2 Proof of Theorem 1 - Optimal weights for small q
Similarly to Section 9.1, we introduce the new set of variables ci := Φ
−1(qwi). We can equivalently
rewrite our problem as
max
c∈RJ
J∑
i=1
Φ
(
ci − ηi
γi
)
s.t.
J∑
i=1
Φ(ci) = qJ.
Clearly it is enough to find a scalar dual variable λ such that we can solve the Lagrangian
problem
max
c∈RJ
J∑
i=1
Φ
(
ci − ηi
γi
)
− λ
(
J∑
i=1
Φ(ci)− qJ
)
s.t.
J∑
i=1
Φ(ci) = qJ.
The strategy is to study this penalized objective for each fixed λ, find maximizers ci(λ), and
then find a suitable λ to make the constraint hold.
For this we introduce a function f(c; η, γ) that is the generic term in the Lagrangian function
of the problem:
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f(c; η, γ) = Φ
(
c− η
γ
)
− λΦ(c).
We find the maximizer of f in the following lemma.
Lemma 9.1. If λ ≥ 1, then the maximum of f is reached at
c1(η, γ;λ) = −
η + γ
√
η2 + 2 (γ2 − 1) log(γλ)
γ2 − 1 . (6)
This function was called c in the main paper. Here we call it c1 to distinguish it from the
dummy variable c.
Proof. Denoting the standard normal density by ϕ, the derivative of f with respect to c is:
∂f(c; η, γ)
∂c
=
1
γ
ϕ
(
c− η
γ
)
− λϕ(c).
Thus ∂f/∂c ≥ 0 if and only if
c2 −
(
c− η
γ
)2
≥ 2 log(γλ). (7)
By assumption γ > 1. We have a quadratic inequality for c, and the associated quadratic
equation has two roots c1, c2. If λ ≥ 1 both roots are real: c1 ≤ c2. Indeed it is easy to check that
the smaller root is given in (6). Then f is increasing on (−∞, c1] and [c2,∞), and decreasing on
[c1, c2]. Further, the limit of f at −∞ is clearly 0, while at ∞ it is 1− λ. Therefore, if λ ≥ 1, c1 is
a global maximum of f .
Therefore, if λ ≥ 1, the i-th summand in the Lagrangian is maximized at c1(ηi, γi, λ). To solve
our problem it is enough to find a λ ≥ 1 such that ∑Ji=1 Φ(c1(ηi, γi, λ)) = Jq.
Such a λ exists by condition (5), as follows: c1 is a decreasing function of λ, thus the constraint
λ ≥ 1 is equivalent to the sum of Φ(c1) evaluated at λ = 1 to be greater than Jq. This is exactly
the condition we assumed in (5). This finishes the proof.
9.3 Proof of Proposition 2 - Recovering the Spjotvoll weights
Let R2 :=
(
γ2 − 1) (η2 + 2γ2 log(γλ)). Then c1(η, γ;λ) equals after some calculation:
c1 = −η +
√
η2 +R2
γ2 − 1 = −
R2√
η2 +R2 − η
1
γ2 − 1 = −
η2 + 2γ2 log(γλ)√
η2 +R2 − η .
As σ → 0, we have γ → 1, γ2 log(γλ) → log(λ), and R2 → 0. For η < 0 this shows that the
limit of c1 is
−η
2 + 2 log(λ)
|η| − η =
η2 + 2 log(λ)
2η
.
Recall that the Spjotvoll weight is
w(µ) = Φ
(
µ
2
+
c
µ
)
/q.
This shows that the we recover the Spjotvoll weights in the limit as σ → 0.
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9.4 Proof of Proposition 3 - Simple sufficient condition
We start by showing that for λ = 1
c1(η, γ;λ) ≥ −η
2 + γ2 log(γ2)
2|η| .
Indeed, for negative η < 0 the left hand side equals:
−
η + γ
√
η2 + (γ2 − 1) log(γ2)
γ2 − 1 = −
η2 + γ2 log(γ2)
|η|+ γ
√
η2 + (γ2 − 1) log(γ2)
and now the inequality follows immediately, because γ ≥ 1, so
γ
√
η2 + (γ2 − 1) log(γ2) ≥ γ
√
η2 ≥ |η|.
Thus the condition (5) of the theorem is satisfied if the following more explicit inequality holds.
J∑
i=1
Φ
(
−η
2
i + γ
2
i log(γ
2
i )
2|ηi|
)
≥ Jq. (8)
For this to hold it is clearly sufficient that there are M distinct indices such that (recall α = Jq)
Φ
(
−η
2
i + γ
2
i log(γ
2
i )
2|ηi|
)
≥ α/M. (9)
The above inequality is equivalent to
|ηi|
2
+
γ2i log(γ
2
i )
2|ηi| ≤ |zα/M |.
By assumption there are M indices such that |ηi|/2 ≤ |zα/M |/2 and γ2i log(γ2i )/(2|ηi|) ≤
|zα/M |/2. For these indices (9) is true, so that (8) holds. This shows that the original condi-
tion (5) holds, finishing the proof.
9.5 Proof of Theorem 2 - Optimal weights in the general case
The proof builds on Theorem 1, but requires more detailed analysis. There are two parts: under-
standing the monotonicity of the generic term in the Lagrangian, then using it to find the optimal
weights.
9.5.1 Monotonicity of the generic term
We saw in Lemma 9.1 that if λ ≥ 1, f is maximized at c1. We also saw in the proof that there are
two cases: the roots of (7) are either real or complex. If the roots are complex, then f is increasing
and the supremum is at +∞. The two roots are complex when the discriminant of the quadratic
equation is negative:
η2 + 2
(
γ2 − 1) log(γλ) < 0.
This inequality is equivalent to the following bound for λ, in terms of a new function l(η, γ):
λ < l(η, γ) :=
1
γ
exp
(
− η
2
2(γ2 − 1)
)
. (10)
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Therefore if λ < l(η, γ), then the supremum of f is at c = +∞. Otherwise there are two
candidates for the supremum: c = +∞ and c1. We want to compare the two candidate maxima.
Denote the limit of f at infinity by p∞(λ) = p∞(λ; η, γ) and the value of f at c1, when defined, as
p1(λ) = p1(λ; η, γ) = f(c1). Let the difference between the two extrema be d(λ; η, γ) = p1(λ; η, γ)−
p∞(λ, η, γ). In the following lemma we find the maximizer of f as a function of λ.
Lemma 9.2. There is a unique value k(η, γ) in the interval [l(η, γ), 1] such that d(k(η, γ); η, γ) = 0.
For λ < k(η, γ), the supremum of f is at +∞, else it is at c1. For the special value λ = k(η, γ)
both values are equal.
Proof. We have explicitly p∞(λ) = 1 − λ and thus p∞ decreases linearly from 1 to 0 on the unit
interval [0, 1]. We also have by definition
p1(λ) = Φ
(
c1(η, γ;λ)− η
γ
)
− λΦ(c1(η, γ;λ)).
Differentiating this expression with respect to λ reveals
∂p1
∂λ
=
1
γ
ϕ
(
c1 − η
γ
)
∂c1
∂λ
−
(
λϕ(c1)
∂c1
∂λ
+ Φ(c1)
)
.
However, by the definition of c1 we have ϕ((c1 − η)/γ) − λϕ(c1) = 0. Indeed, c1 was defined
as one of the extrema of f , which leads to the above equation by taking derivatives. Hence the
expression above simplifies to: ∂p1/∂λ = −Φ(c1).
This shows that p1 is decreasing in λ: the derivative belongs to (−1, 0). We also know that
p1 > 0, because the value p1 is a local maximum of f in c, and we have seen that f - as a function
of c - increases from 0 (a value which it takes in the limit at −∞) to f(c1) - and hence p1 = f(c1)
must necessarily be positive. We conclude that p1(1) > 0 = p∞(1)
Finally, we note that p1(λ) is well-defined precisely when c1(λ) is. This happens when the
expression inside the square root is non-negative, which means λ ≥ l(η, γ).
To summarize
• d is defined on the interval λ ∈ [l(η, γ), 1].
• d is a strictly increasing differentiable function on this interval, because its derivative is
∂d
∂λ = 1− Φ(c1) > 0.
• d(1) > 0.
If we show that d has a unique root k, our conclusion will follow. Given the above three
statements, it’s enough to show that d(l(η, γ)) < 0; then the claim follows by the intermediate
value theorem.
To check the condition d(l(η, γ)) < 0 we note that c1(l(η, γ)) = − ηγ2−1 , hence p1(l) < p∞(l) is
equivalent to
Φ
(
− ηγ
γ2 − 1
)
− lΦ
(
− η
γ2 − 1
)
< 1− l,
or after some rearrangement lΦ
(
η
γ2−1
)
< Φ
(
ηγ
γ2−1
)
.
Introducing the variable x = η
γ2−1 and eliminating η by noting l = exp(−x2(γ2 − 1)/2)/γ we
obtain that all we need to show is
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exp
(
x2
2
)
Φ(x) ≤ exp
(
(γx)2
2
)
Φ(γx)γ.
If η < 0, then x < 0, and the above will follow if the function m(x) = x exp
(
x2
2
)
Φ(x) is strictly
increasing on (−∞, 0]. Checking this is an elementary calculus exercise. The cases η = 0 and η > 0
are handled similarly. This finishes the proof.
9.5.2 Method for computing weights
In the previous section, we saw that for any i, if λ < ki := k(ηi, γi), then the supremum of f(·; ηi, γi)
occurs at +∞, else it occurs at c1(ηi, γi;λ). For the optimal weights this shows:
wi(ηi, γi;λ) =

Φ(c1(ηi, γi;λ))/q if λ > k(ηi, γi),
Φ(c1(ηi, γi;λ))/q or 1/q if λ = k(ηi, γi),
1/q if λ < k(ηi, γi).
We emphasize that the value of wi can take either of two values for λ = k(ηi, γi). We will
unambiguously specify a choice later for each i, determined by the constraint on the sum of the
weights.
Now all that remains is to search for a suitable λ such that the weights sum to J :
∑
iwi = J .
If we find such a λ, then by duality the weights wi will solve our original problem. Let us denote
the sum of the weights by W :
W (λ) =
J∑
i=1
wi(ηi, γi;λ).
The function W (λ) is unambiguously defined for λ 6= ki, which is what we will use at first.
Each function wi is decreasing in λ: constant on the interval (0, ki), and decreasing smoothly
from ri = Φ(c1(ηi, γi; ki))/q to 0 on the interval (ki,∞). Further, the function wi has a jump of
size (1− ri)/q at ki.
Therefore W is a decreasing function of λ on [0,∞), going from J/q to 0. Further, if we sort the
values ki such that k(0) = 0 < k(1) ≤ . . . ≤ k(J) < k(J+1) = ∞, then W is smooth on the intervals
(k(i), k(i+1)), and has jumps of size (1− r(i))/q at k(i) for 1 ≤ i ≤ J .
Hence, for our problem of solving W (λ) = J , there are two possibilities:
Case 1 There is an interval (k(i), k(i+1)) such that J belongs to the image of this interval under
W . In this case, since the function W is strictly decreasing and continuous on this interval, there
will exist a unique λ in the interval such that W (λ) = J . In this case we can solve the original
problem exactly.
Case 2 There is no such interval. In this case, the present duality approach is unable to produce
an exact solution to the original problem.
However, we can get an approximate solution. Let us consider the values W (ki). Above we
noted that wi(ki) can take two possible values 1/q and ri. Hence W can also take more than
one value at ki. Since several ki may be equal, W may take more than two possible values,
because each summand wi can be chosen in two ways. To understand this, let us call the distinct
values of ki to be Kj , and assume K1 < K2 < . . . < KL. For brevity let us also add K0 = 0,
KL+1 = ∞. Without loss of generality, we assume that the values ki cluster in the following way:
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K1 = k(1) = k(2) = . . . = k(i1), K2 = k(i1+1) = . . . = k(i2), and so on. We also define the sets Si
containing the indices j for which kj = Ki.
The value of W is now defined unambiguously on each interval (Ki,Ki+1), and W is a smooth
decreasing function on this interval. At Km, W has a jump of size
jm =
∑
i:ki=Km
1− r(i)
q
=
im+1 − im −
∑im+1
i=im+1
r(i)
q
.
By assumption, in the current case there is no interval (Ki,Ki+1) whose image under W contains
J . Therefore J is contained in one of the jumps occurring between these intervals, say the jump
at Ki. Let us now choose λ = Ki. Let us also define the left and right limits of W at Ki:
a+ = limx→Ki,x<KiW (x), a− = limx→Ki,x>KiW (x).
Then a− < a+ and the current case entails that J ∈ [a−, a+]. Let us also denote the values of
the jumps by the more compact notation si = (1− r(i))/q. With these notations, we can now easily
state that the possible values of W (Ki) are, for any set S ⊂ Si
W (Ki, S) = a− +
∑
t∈S
st.
These consitute at most 2|Si| different values, but some of them may be equal. Nonetheless,
the values si are between 0 and 1/q, so for any value x ∈ [a−, a+], we can find a suitable subset S
such that W ∗ = W (Ki, S) approximates x within 1/(2q). In fact, for any ordering of the st values
st1 , st2 , . . . , st|Si| , looking at the two cumulative sums st1 + st2 + . . . + stk scoring nearest to x, we
can find one closer than 1/(2q). This shows that the desired subset can be found in O(|Si|) steps;
with more work we can possibly find a better packing.
For this choice of the values wi, the sum of wi equals W
∗, and |W ∗−J | ≤ 1/(2q). To summarize
this second case: Even if we can’t find a dual variable λ such that the constraint is satisfied, we
can find one such that the sum of wi equals W
∗, and |W ∗ − J | ≤ 1/(2q).
In fact we have found the exact optimal weights for a slightly different problem. Define the scaled
weights w˜i = Jwi/W
∗, then w˜i solves the optimization problem 3 with the parameter q replaced
by q∗ = W ∗q/J . This is clear if we notice that the optimization problem can be parametrized by
q, and everything we’ve said so far holds for each fixed q. Thus, for any value of W ∗, we just need
to find a value q∗ such that the constraint holds. This amounts to
J∑
i=1
Φ(ci) = W
∗q = q∗J
and we find the claimed equation for q∗. Further |q∗ − q| = |q(J −W ∗)/J | ≤ 1/(2J), as desired.
This finishes the proof that q∗ exists, we just need to show how to find it.
Final algorithm The final algorithm is sumarized in Algorithm 2. We compute the values ki
for each i, using Brent’s method on the equation d(k) = 0. This takes O(J) steps. Next, we sort
the unique values ki (O(J log J) steps), and do a binary search on the values W (ki) to find the
right interval for λ. Calculating a value W (λ) takes O(J) steps. The binary search takes O(log J)
function evaluations of W , making the total cost of this step O(J log J).
Once we found the right interval, we have to deal with the two possibilities identified above.
If there is an exact solution W (λ) = J , then after finding the right interval, Brent’s method is
used to solve the equation (O(J) steps). On this interval, the function W is smooth with explicitly
computable derivatives. If there is no exact solution, then we simply return the closest interval
endpoint (O(J) steps). The overall cost is O(J log J).
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Algorithm 2 Method to compute weights
1: ηi, σ
2
i ← prior means and variances i = 1, . . . , J
2: q ← significance threshold
3: if condition (5) holds then
4: Solve
∑
i Φ(c1(ηi, γi, λ)) = Jq for λ ∈ [1,∞) using Newton’s method
5: return wi = Φ(c1(ηi, γi, λ))/q, q
∗ = q
6: else
7: Define d(λ; η, γ) = λΦ(−c1(η, γ;λ))− Φ (−(c1(η, γ;λ)− η)/γ)
8: for all i Solve d(ki; ηi, γi) = 0 for ki ∈ [l(ηi, γi), 1] using Brent
9: Let the sorted unique values ki be K(i)
10: Define w−i (λ) =
{
Φ(c1(ηi, γi;λ))/q if λ ≥ ki
1/q if λ < ki
11: Define si(λ) = I(λ = ki)(1/q − w−i (λ))
12: Define w+i (λ) = w
−
i (λ) + si(λ)
13: Define W+(λ) =
∑
iw
+
i (λ) and W
−(λ) =
∑
iw
−
i (λ)
14: Find the index j for which W+(K(j)) ≥ Jq > W+(K(j+1)) via binary search
15: if W−(K(j)) ≥ Jq > W+(K(j+1)) then
16: Solve W+(λ) = Jq for λ ∈ [K(j),K(j+1)) using Brent
17: return wi = w
+
i (λ), q
∗ = q
18: else
19: Find the indices S = {j1, . . . , jn} such that kji = K(i)
20: Find the largest index T such that r− := W−(K(j)) +
∑
i≤T Sji(K(j)) ≤ Jq
21: Define r+ = r− + SjT+1(K(j))
22: Let W ∗ be the closer of r−, r+ to Jq (break ties arbitrarily)
23: Define w∗i =

w+i (K(j)) if i /∈ S
w+i (K(j)) if i = jk, for k > T + 1
w−i (K(j)) if i = jk, for k ≤ T
w±i (K(j)) if i = jT+1, depending on the choice of r
±
24: return w˜i = Jw
∗
i /W
∗, q∗ = W ∗q/J .
10 Data sources
10.1 CARDIoGRAM - CAD
This is a meta-analysis of 14 coronary artery disease (CAD) GWAS, comprising 22,233 cases and
64,762 controls of European descent (Schunkert et al., 2011). The study includes 2.3 million SNPs.
In each of the 14 studies and for each SNP, a logistic regression of CAD status was performed on
the number of copies of one allele, along with suitable controlling covariates. The resulting effect
sizes were combined across studies using fixed effects or random effects meta-analysis with inverse
variance weighting.
10.2 C4D - CAD
This is a meta-analysis of 5 heart disease GWAS, totalling 15,420 CAD cases and and 15,062 controls
(Coronary Artery Disease (C4D) Genetics Consortium, 2011). The samples did not overlap those
from CARDIoGRAM. The analysis steps were similar to CARDIoGRAM.
21
10.3 Chronic Kidney Disease Consortium (CKDGen) - eGFR creatinine
This is a GWAS of kidney traits in 67,093 participants of European ancestry from 20 population-
based cohorts (Ko¨ttgen et al., 2010). eGFR creatinine (eGFRcrea) was the trait with the largest
sample size. There is no reported overlap with the samples from C4D. The analysis steps were
similar to the previous two studies.
10.4 Blood Lipids
This is a GWAS of blood lipids in a sample from European populations (Teslovich et al., 2010).
Triglyceride levels (TG) were one of the traits, with sample size 96,598, chosen here out of all lipids
because of its previous appearance in (Andreassen et al., 2013). Standard protocols for GWAS
were used: linear regression analysis with study-specific covariates, combined using fixed-effects
meta-analysis.
10.5 Psychiatric Genomics Consortium - Schizophrenia
This is a mega-analysis (i.e. using the raw data not just summaries) combining GWAS data
from 17 separate studies of schizophrenia (SCZ), with a total of 9,394 cases and 12,462 controls
(Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium, 2011). They
tested for association using logistic regression of SCZ status on the allelic dosages. The overlap
with the blood lipids study consists of 1,459 controls (12% of controls in the SCZ study), from the
British 1958 Birth Cohort of the Wellcome Trust Case Control Consortium.
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